Search research articles
Contact Us
Filters
Showing results (71-80 of 75) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 75 results.
The Journal of Urology
|
June 7, 2006
Are bone scans necessary in men with low prostate specific antigen levels following localized therapy?
K S Warren, G W Chodak, W A See, et al.
American Journal of Epidemiology
|
March 1, 2000
Tea consumption and risk of bladder and kidney cancers in a population-based case-control study
G D Bianchi, J R Cerhan, A S Parker, et al.
The Journal of Pathology
|
November 1, 2008
SmgGDS is up-regulated in prostate carcinoma and promotes tumour phenotypes in prostate cancer cells
H Zhi, X J Yang, J Kuhnmuench, et al.
BJU International
|
December 19, 2000
Biomarker distribution after injection into the canine prostate: implications for gene therapy
D R Siemens, T Iwasawa, J C Austin, et al.
Urology
|
July 1, 1996
Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial
M F Sarosdy, B A Lowe, P F Schellhammer, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 75) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 75 results.
The Journal of Urology
|
June 7, 2006
Are bone scans necessary in men with low prostate specific antigen levels following localized therapy?
K S Warren, G W Chodak, W A See, et al.
American Journal of Epidemiology
|
March 1, 2000
Tea consumption and risk of bladder and kidney cancers in a population-based case-control study
G D Bianchi, J R Cerhan, A S Parker, et al.
The Journal of Pathology
|
November 1, 2008
SmgGDS is up-regulated in prostate carcinoma and promotes tumour phenotypes in prostate cancer cells
H Zhi, X J Yang, J Kuhnmuench, et al.
BJU International
|
December 19, 2000
Biomarker distribution after injection into the canine prostate: implications for gene therapy
D R Siemens, T Iwasawa, J C Austin, et al.
Urology
|
July 1, 1996
Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial
M F Sarosdy, B A Lowe, P F Schellhammer, et al.
Page
of 8